Rivastigmine and Fatigue aggravated - a phase IV clinical study of FDA data

Summary:

Fatigue aggravated is reported as a side effect among people who take Rivastigmine (rivastigmine tartrate), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Nuplazid, and have Parkinson's disease.

The phase IV clinical study analyzes which people have Fatigue aggravated when taking Rivastigmine. It is created by eHealthMe based on reports of 7,475 people who have side effects when taking Rivastigmine from the FDA, and is updated regularly.

What is Rivastigmine?

Rivastigmine has active ingredients of rivastigmine tartrate. It is often used in dementia. eHealthMe is studying from 7,517 Rivastigmine users. Check the latest studies of Rivastigmine.

What is Fatigue aggravated?

Fatigue aggravated (feeling of tiredness) is found to be associated with 3,163 drugs and 1,117 conditions by eHealthMe. Check the latest studies of Fatigue aggravated.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

7,475 people reported to have side effects when taking Rivastigmine.
Among them, 577 people (7.72%) have Fatigue aggravated.

Could Rivastigmine cause Fatigue aggravated?

Among these 577 people:

How long have people been on Rivastigmine when they have Fatigue aggravated? *

Click here to view more results

What is the gender of people who have Fatigue aggravated when taking Rivastigmine? *

Click here to view

What is the age of people who have Fatigue aggravated when taking Rivastigmine? *

Click here to view more results

* Approximation only. Some reports may have incomplete information.

Do you take Rivastigmine and have Fatigue aggravated?

- Check whether Fatigue aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Rivastigmine:

Rivastigmine (7,517 reports)

Fatigue aggravated treatments and more:

Fatigue aggravated (252 reports)

How severe was Fatigue aggravated and when was it recovered:

Fatigue aggravated in Rivastigmine

Expand to all the drugs that have ingredients of rivastigmine tartrate:

Fatigue aggravated and drugs with ingredients of rivastigmine tartrate

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Rivastigmine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Fatigue aggravated:

Fatigue aggravated (3,163 drugs)

Browse all the conditions that are associated with Fatigue aggravated:

Fatigue aggravated (1,117 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on rivastigmine tartrate (the active ingredients of Rivastigmine) and Rivastigmine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.